Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
Trends in Immunology|September 14, 2010
Impaired Toll-like receptor 7 and 9 signaling: from chronic viral infections to cancerIvan Hirsch, Christophe Caux, Uzma Hasan, et al.Trends in Immunology|May 11, 2013
MyD88 and its divergent toll in carcinogenesisRosalba Salcedo, Christophe Cataisson, Uzma Hasan, et al.Virus Genes|October 20, 2009
The biological properties of E6 and E7 oncoproteins from human papillomavirusesRaffaella Ghittoni, Rosita Accardi, Uzma Hasan, et al.Cancers|April 13, 2023
Immune Environment and Immunotherapy in Endometrial Carcinoma and Cervical TumorsAlexandra Lainé, Andrea M Gonzalez-Lopez, Uzma Hasan, et al.Artificial Intelligence in Medicine|March 3, 2023
Structural causal model with expert augmented knowledge to estimate the effect of oxygen therapy on mortality in the ICUMd Osman Gani, Shravan Kethireddy, Riddhiman Adib, et al.Autoimmunity Reviews|August 14, 2015
Inherited anomalies of innate immune receptors in pediatric-onset inflammatory diseasesCécile Picard, Anne-Laure Mathieu, Uzma Hasan, et al.Acta Biomaterialia|March 12, 2023
Biomaterial-based platforms for modulating immune components against cancer and cancer stem cellsNimeet Desai, Uzma Hasan, Jeyashree K, et al.Pediatric Emergency Care|April 22, 2009
Management of occult fractures in the skeletally immature patient: cost analysis of implementing a limited trauma magnetic resonance imaging protocolJ Herman Kan, Cristina Estrada, Uzma Hasan, et al.Eukaryotic Cell|October 4, 2011
Functional analysis of the exported type IV HSP40 protein PfGECO in Plasmodium falciparum gametocytesBelinda J Morahan, Carolyn Strobel, Uzma Hasan, et al.Virology|June 15, 2007
E7 properties of mucosal human papillomavirus types 26, 53 and 66 correlate with their intermediate risk for cervical cancer developmentMariam Mansour, Majid Touka, Uzma Hasan, et al.Pageof 4